Registration Header
REGISTER TODAY!

Molecular Partners Investor Day 2020

Start Date:12/17/2020

Start Time:9:00 AM EST

Duration:180 minutes

Abstract:

Molecular Partners plans to share updates on its oncology programs and preliminary data from the Phase 1 study of MP0420, which is being developed for the treatment of COVID-19 under a collaboration with Novartis. In addition, Patrick Amstutz, Ph.D., Chief Executive Officer of Molecular Partners will describe the Company’s strategy for portfolio growth and expansion.

If you're already registered for the Molecular Partners Investor Day 2020 webcast, click below:

ALREADY REGISTERED?
First Name
Last Name
Company
Email Address